CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- NT 10-Q Other NT 10-Q
- 10KSB/A Other 10KSB/A
- 10KSB Other 10KSB
- NT 10-K Other NT 10-K
- 8-K Event Material agreement · Debt accelerated
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 10QSB Other 10QSB
- NT 10-Q/A Other NT 10-Q/A
- NT 10-Q Other NT 10-Q
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10QSB Other 10QSB
- REGDEX Other REGDEX
- 3 Insider Initial Statement of Ownership
- 10QSB Other 10QSB
- NT 10-Q Other NT 10-Q
- S-8 POS Other Post-effective Amendment
- 10QSB/A Other 10QSB/A
- 10KSB Other 10KSB
- NT 10-K Other NT 10-K
Page 39 of 46 · 904 filings